Predictive Health Diagnostics (PHD) has secured a new $5MM investment from a strategic partner at an attractive pre-money valuation of $45MM. Visionary completed its investment in PHD less than one year ago and has witnessed strong growth and adoption of its novel and disruptive PULS tests, used to accurately detect the likelihood of a coronary event, in the asymptomatic but high-risk patient population (Fox Business News video: New Blood Test Could Help Prevent Heart Attacks).
— VPEG Portfolio Company Predictive Health Diagnostics Secures Additional $5MM “Up Round” Financing